Sientra CEO on Resilient Growth, Pushing the Field of Plastic Surgery Forward
By Alan Hatfield Sientra, Inc. (Nasdaq: SIEN) is a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery. IPO...
Sientra CEO on Resilient Growth, Pushing the Field of Plastic Surgery Forward
By Alan Hatfield Sientra, Inc. (Nasdaq: SIEN) is a medical aesthetics company focused on...
ICR President Don Duffy on Upcoming SPAC Expirations and Liquidations at 2022 IPO Edge Spring Forum
Don Duffy, President, ICR, talks about SPAC expiration dates in the first half of...
Nasdaq Global Head of SPACs Eklavya Saraf Discusses Creative and Unique Transaction Types at 2022 IPO Edge Spring Forum
Eklavya Saraf, Global Head of SPACs, Nasdaq, discusses creative and unique transaction types made...
Cowen Capital Markets Managing Director Chris Weekes on Reduced SPAC Transaction Volume at 2022 IPO Edge Spring Forum – Video
Chris Weekes, Managing Director, Capital Markets, Cowen, anticipates reduced transaction volume compared to last...
Gallagher SPAC Segment National Director John Marchisi on Readiness From Announcement Through Transaction at 2022 IPO Edge Spring Forum – Video
John Marchisi, National Director, SPAC Segment, Gallagher, discusses readiness of program and of conduct...
Vinson & Elkins Mergers & Acquisitions Partner Ramey Layne on Need for Differentiated Rules for SPACs vs. IPOs at 2022 IPO Edge Spring Forum – Video
Ramey Layne, Partner, Mergers & Acquisitions, Vinson & Elkins, points to the need for...
Video Highlights – The SPAC Commandments: Join IPO Edge Spring Forum with Gallagher, Cowen, Nasdaq, ICR, Vinson & Elkins, Knightswan
The SEC and Elizabeth Warren have SPACs in their crosshairs, but what will the...
